In support of, and complementary to our findings, are the results described in a concurrent study published by Yao et al. showing a role for PRMT7 in promoting epithelial-to-mesenchymal transition (EMT) and breast cancer cell metastasis [67]. Here, PRMT7 is linked to breast carcinoma.